Hollings Renton
Chief Executive Officer, Onyx Pharmaceuticals.
Companies
- ANAPTYSBIO, INCBoard member Jan 25, 2017 to now1
- ZymeworksBoard member Dec 23, 2022 to Dec 8, 20232
- ZymeworksBoard member Jan 2, 2019 to May 7, 20213
- RIGEL PHARMACEUTICALS INCBoard member May 31, 2006 to May 28, 20134
- Onyx PharmaceuticalsBoard member Jan 20, 2006 to Feb 26, 20085
- Onyx PharmaceuticalsChief executive officer Jan 20, 2006 to Feb 26, 20085
- Onyx PharmaceuticalsPresident Jan 20, 2006 to Feb 26, 20085
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ANAPTYSBIO, INC ANAB10,995 shares6$521.4K at $47.42Jun 15, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 15, 2026Exercised options 6,030 shares of ANAPTYSBIO, INC6
- Aug 8, 2025Sold 7,121 shares at $19.70 of ANAPTYSBIO, INC7
- Aug 8, 2025Sold 3,110 shares at $19.44 of ANAPTYSBIO, INC7
- Aug 8, 2025Exercised options 10,231 shares at $6.93 of ANAPTYSBIO, INC7
- Jul 2, 2025Sold 13,675 shares at $23.82 of ANAPTYSBIO, INC8
- Jul 2, 2025Sold 7,250 shares at $23.09 of ANAPTYSBIO, INC8
- Jul 2, 2025Exercised options 20,925 shares at $6.93 of ANAPTYSBIO, INC8
- Jun 18, 2025Sold 3,015 shares at $23.97 of ANAPTYSBIO, INC9
- Jun 15, 2025Exercised options 6,030 shares of ANAPTYSBIO, INC10
- Nov 29, 2024Sold 10,000 shares at $25.00 of ANAPTYSBIO, INC11
- Nov 29, 2024Exercised options 10,000 shares at $6.93 of ANAPTYSBIO, INC11
- Jul 15, 2024Sold 2,897 shares at $30.98 of ANAPTYSBIO, INC12
- Jul 15, 2024Sold 7,103 shares at $30.50 of ANAPTYSBIO, INC12
- Jul 15, 2024Exercised options 10,000 shares at $6.93 of ANAPTYSBIO, INC12
- Jun 18, 2024Sold 1,950 shares at $23.16 of ANAPTYSBIO, INC13
- Jun 15, 2024Exercised options 3,900 shares of ANAPTYSBIO, INC13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARANAPTYSBIO, INC, Board member
- 2SEC EDGARZymeworks, Board member
- 3SEC EDGARZymeworks, Board member
- 4
- 5SEC EDGAROnyx Pharmaceuticals, Board member
- 6
- 7SEC EDGARForm 4 filed Aug 12, 2025
- 8SEC EDGARForm 4 filed Jul 3, 2025
- 9SEC EDGARForm 4 filed Jun 20, 2025
- 10SEC EDGARForm 4 filed Jun 17, 2025
- 11SEC EDGARForm 4 filed Dec 3, 2024
- 12SEC EDGARForm 4 filed Jul 17, 2024
- 13SEC EDGARForm 4 filed Jun 18, 2024